Jove
Visualize
Contact Us

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

4.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.8K
Disorders of Hemostasis01:24

Disorders of Hemostasis

739
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
739
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

3
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The fibrinogen αC region promotes arterial thrombosis in the context of hypofibrinogenemia.

Blood·2026
Same author

[Abnormal uterine bleeding and hemostasis disorders].

Revue medicale suisse·2024
Same author

A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec.

Haemophilia : the official journal of the World Federation of Hemophilia·2024
Same author

Haemophilia : the official journal of the World Federation of Hemophilia·2024
Same author

How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause.

International journal of laboratory hematology·2024
Same author

Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.

Blood advances·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 12, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

How I treat quantitative fibrinogen disorders.

Alessandro Casini1

  • 1Division of Angiology and Hemostasis, University Hospitals of Geneva, Geneva, Switzerland; and Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Blood
|December 19, 2024
PubMed
Summary

Quantitative fibrinogen disorders, like afibrinogenemia and hypofibrinogenemia, involve low or absent fibrinogen. Management of bleeding, thrombosis, surgery, and pregnancy requires careful fibrinogen replacement and thromboprophylaxis strategies.

More Related Videos

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.2K

Related Experiment Videos

Last Updated: Jun 12, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.2K

Area of Science:

  • Hematology
  • Genetics
  • Clinical Medicine

Background:

  • Quantitative fibrinogen disorders (afibrinogenemia, hypofibrinogenemia) are monogenic conditions characterized by absent or reduced fibrinogen.
  • Severity correlates with fibrinogen levels, impacting bleeding risk from mild to life-threatening.
  • These disorders present unique challenges in managing bleeding, thrombosis, surgery, and pregnancy.

Purpose of the Study:

  • To present clinical scenarios illustrating common challenges in managing quantitative fibrinogen disorders.
  • To propose evidence-based strategies for addressing bleeding, thrombosis, surgical interventions, and pregnancy in affected individuals.

Main Methods:

  • Diagnosis relies on measuring fibrinogen activity and antigen levels.
  • Case-based approach presenting 4 distinct clinical scenarios.
  • Review of current literature and clinical guidelines for management strategies.

Main Results:

  • Afibrinogenemia typically involves severe bleeding, while hypofibrinogenemia ranges from asymptomatic to mild bleeding.
  • A prothrombotic tendency exists, potentially worsened by fibrinogen supplementation.
  • Management requires tailored fibrinogen replacement and thromboprophylaxis, especially during surgery and pregnancy.

Conclusions:

  • Effective management of quantitative fibrinogen disorders necessitates a comprehensive approach addressing bleeding, thrombosis, and specific life events.
  • Clinical scenarios highlight the complexity and need for individualized treatment strategies.
  • Further research may refine optimal therapeutic protocols for these rare conditions.